510(k) · Cleared
ClearedXTRA
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Sorin Group Deutschland GmbH · CAC Apparatus, Autotransfusion
Cleared on Mar 21, 2014 as substantially equivalent to K112245 (Sorin Group Italia S.R.L., 2011) after a 295-day review. Its family tree reaches back 5 generations to 1989.
- Decided
- Mar 21, 2014
- Review
- 295 days
- Class
- Class II
- Product code
- CAC
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 5 generations to K884564 (1989). 10 ancestors in all. No later device cites it as a predicate yet.
- Root · 5 generations backK884564 Shiley Therapeutic Autotransfusion System-ProgrammShiley, Inc. · 1989
- 4 generations backK982650 Autologous Blood Management System (Abms)Dideco S.P.A. · 1998 · Recalled
- 3 generations backK020647 Dideco ElectaDideco S.P.A. · 2002 · Recalled
- 2 generations backK101586 Xtra Autotransfusion SystemSorin Group Italia S.R.L. · 2010
- 1 generation backK112245 XTRASorin Group Italia S.R.L. · 2011
- This deviceK131553 XTRASorin Group Deutschland GmbH · 2014
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −5 | K884564 | Shiley Therapeutic Autotransfusion System-Programm | Shiley, Inc. | 1989 | — |
| −4 | K982650 | Autologous Blood Management System (Abms) | Dideco S.P.A. | 1998 | 2 |
| −3 | K020647 | Dideco Electa | Dideco S.P.A. | 2002 | 2 |
| −2 | K101586 | Xtra Autotransfusion System | Sorin Group Italia S.R.L. | 2010 | — |
| −1 | K112245 | XTRA | Sorin Group Italia S.R.L. | 2011 | — |
| 0 (this device) | K131553 | XTRA | Sorin Group Deutschland GmbH | 2014 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1991 | 1 | 0 |
| 1995 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in CAC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new CAC device
- #1 K240426 Aventus Clot Management Systemscore 11.2 · 4 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K112245 | XTRASummary page 1…ion CLASSIFICATION CODE: CAC REGULATION NUMBER: 868.5830 UNMODIFIED DEVICE(S): XTRA Autotransfusion System (K112245) DEVICE DESCRIPTION: XTRA is an Autotransfusion System designed to recover shed blood during intraoperative and postoperative p… | 2011 |
| † | K101586 | Xtra Autotransfusion System | 2010 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 25 years and passes through 4 companies; a new generation was cleared every 3.7 years on median.
- 2 of the 10 ancestors have a recall of any class.
How does its category compare?
All CAC devicesCAC Apparatus, Autotransfusion: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.
FDA decisions per year · CAC
3in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · CAC
91in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · CAC
7in 2023
Class I (2 since 2007) Class II/III not classified
Adverse event reports per year · CAC
128in 2025
MAUDE reports naming product code CAC, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 1 | 35 |
| 2008 | 1 | — | 5 | 12 |
| 2009 | 0 | — | 25 | 68 |
| 2010 | 4 | 123 | 3 | 115 |
| 2011 | 2 | — | 3 | 939 |
| 2012 | 3 | 90 | 0 | 249 |
| 2013 | 1 | — | 9 | 153 |
| 2014 | 3 | 269 | 0 | 90 |
| 2015 | 0 | — | 0 | 87 |
| 2016 | 2 | — | 0 | 73 |
| 2017 | 1 | — | 2 | 88 |
| 2018 | 2 | — | 2 | 87 |
| 2019 | 1 | — | 23 | 64 |
| 2020 | 1 | — | 0 | 108 |
| 2021 | 4 | 155 | 0 | 73 |
| 2022 | 1 | — | 0 | 65 |
| 2023 | 2 | — | 7 (2) | 39 |
| 2024 | 3 | 91 | 0 | 129 |
| 2025 | 0 | — | 0 | 128 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The XTRA Autotransfusion System is indicated for intreoperative recovery of blood, washing of blood collected in the postoperative period, and preoperative sequestration (with indirect patient connection). Typical clinical applications of autotransfusion include the following surgical specialties:
- Cardiovascular
- Orthopedics
- Thoracic
- Transplant Surgery
- Emergency (Trauma)
- Neurosurgery
- Obstetrics and gynecology
- Urology
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K131553 · printed Nov 6, 2026
Cite this page
510(k) Report. “K131553: XTRA.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K131553
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026